Approvals/TGA/CSL New Zealand Tetanus Immunoglobulin-VF (Human Tetanus Immunoglobulin), 250IU, solution for injection, vial

Approved

STANDARD

CSL New Zealand Tetanus Immunoglobulin-VF (Human Tetanus Immunoglobulin), 250IU, solution for injection, vial

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e5d73eb45f7c0d37
Product Name: CSL New Zealand Tetanus Immunoglobulin-VF (Human Tetanus Immunoglobulin), 250IU, solution for injection, vial
Artg Id: 125817
Artg Name: CSL New Zealand Tetanus Immunoglobulin-VF (Human Tetanus Immunoglobulin), 250IU, solution for injection, vial
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2006-03-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e5d73eb45f7c0d37

Type

Standard